中医杂志2026,Vol.67Issue(6):696-701,6.DOI:10.13288/j.11-2166/r.2026.06.017
从湿热伏邪辨治溃疡性结肠炎
Syndrome Differentiation and Treatment of Ulcerative Colitis Based on the Theory of Latent Dampness-Heat Pathogen
摘要
Abstract
It is believed that the latent dampness-heat pathogen constitutes the core pathogenesis of ulcerative colitis(UC),characterized by the pattern of"lurking in the three yin(taiyin,shaoyin,jueyin)and emerging from the three yang(taiyang,shaoyang,yangming)",with a tendency to transform into fire.The pathogenic evolution can be delineated into three stages,the latent stage manifesting as taiyin deficiency with healthy qi deficiency and lingering pathogen,allowing dampness-heat to lurk internally;the active stage involving pathogen penetrating the three yang,with dampness-heat externally erupting,leading to putrefaction of flesh and impairment of blood;the prolonged stage pertaining to jueyin invading the collaterals,with dampness-heat and static blood binding together,culminating in the formation of abdominal masses.The therapeutic approach adopts the strategy of pathogen-expelling by stage.During the latent stage,therapy focuses on fortifying the spleen and promoting pathogens,concurrently clearing and transforming,aiming at eradicating the latent pathogens,using modified Qiwei Baizhu Powder(七味白术散)or self-prescribed Zhaqu Jianpi Decoction(楂曲健脾汤).During the active stage,emphasis is placed on clearing and resol-ving pathogens,promoting stagnation and unblocking obstruction,primarily focusing on providing an outlet for patho-gens,using modified Zhishi Daozhi Decoction(枳实导滞汤)as the main formula.For the prolonged stage involving jueyin invading the collaterals,ingredients that resolve stasis and unblock collaterals,such as Biejia(Lawsonia inermis)and Shuizhi(Cucumis melo),are often prescribed.关键词
溃疡性结肠炎/湿热/伏邪Key words
ulcerative colitis/dampness-heat/latent pathogen引用本文复制引用
李林阳,刘文平,冯全生..从湿热伏邪辨治溃疡性结肠炎[J].中医杂志,2026,67(6):696-701,6.基金项目
教育部人文社会科学研究青年基金(23YJC870002) (23YJC870002)
成都中医药大学基础医学院传承创新发展科研基金(CCCXYB202205) (CCCXYB202205)